tradingkey.logo

Catheter Precision Inc

VTAK
1.770USD
-0.040-2.21%
收盤 12/24, 13:00美東報價延遲15分鐘
2.92M總市值
0.05本益比TTM

Catheter Precision Inc

1.770
-0.040-2.21%

關於 Catheter Precision Inc 公司

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Catheter Precision Inc簡介

公司代碼VTAK
公司名稱Catheter Precision Inc
上市日期Sep 27, 2018
CEOJenkins (David A)
員工數量22
證券類型Ordinary Share
年結日Sep 27
公司地址1670 Highway 160 West
城市FORT MILL
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編29708
電話19736912000
網址https://www.ramed.com/
公司代碼VTAK
上市日期Sep 27, 2018
CEOJenkins (David A)

Catheter Precision Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
22.28K
+118.07%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
22.28K
+118.07%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
173.00K
81.60%
All other countries
39.00K
18.40%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 12月4日 週四
更新時間: 12月4日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Jenkins Family Charitable Institute
2.21%
Jenkins (David A)
1.34%
FatBoy Capital LP
0.22%
Caruso (James Joseph)
0.11%
Manulife Investment Management (North America) Limited
0.03%
其他
96.09%
持股股東
持股股東
佔比
Jenkins Family Charitable Institute
2.21%
Jenkins (David A)
1.34%
FatBoy Capital LP
0.22%
Caruso (James Joseph)
0.11%
Manulife Investment Management (North America) Limited
0.03%
其他
96.09%
股東類型
持股股東
佔比
Corporation
2.43%
Individual Investor
1.47%
Investment Advisor
0.03%
其他
96.07%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
23
24.65K
1.66%
-10.09K
2025Q2
30
1.62M
12.88%
+225.25K
2025Q1
34
1.39M
13.16%
+226.78K
2024Q4
37
1.12M
13.97%
-215.80K
2024Q3
45
563.38K
38.63%
+376.14K
2024Q2
46
202.02K
23.51%
+5.34K
2024Q1
50
211.28K
24.77%
+47.42K
2023Q4
52
169.47K
25.10%
+5.69K
2023Q3
56
180.73K
31.24%
+30.19K
2023Q2
57
168.19K
29.83%
+996.00
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Jenkins Family Charitable Institute
36.85K
2.48%
+10.53K
+39.98%
Jun 05, 2025
Jenkins (David A)
10.22K
0.69%
-2.00
-0.02%
Sep 10, 2025
FatBoy Capital LP
3.73K
0.25%
--
--
Jan 29, 2025
Caruso (James Joseph)
1.84K
0.12%
+10.00
+0.55%
Sep 10, 2025
Jenkins (Casey A)
310.00
0.02%
+16.00
+5.44%
Jun 05, 2025
Jenkins Linda A
12.00
0%
--
--
Jan 29, 2025
BofA Global Research (US)
6.00
0%
+2.00
+50.00%
Jun 30, 2025
Harbour Investments, Inc
8.00
0%
--
--
Jun 30, 2025
SBI Securities Co., Ltd.
58.00
0%
+58.00
--
Jun 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Jul 28, 2025
Merger
19→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
公告日期
類型
比率
Jul 28, 2025
Merger
19→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Nov 16, 2020
Merger
25→1
查看更多

常見問題

Catheter Precision Inc的前五大股東是誰?

Catheter Precision Inc的前五大股東如下:
Jenkins Family Charitable Institute
持有股份:36.85K
佔總股份比例:2.48%。
Jenkins (David A)
持有股份:10.22K
佔總股份比例:0.69%。
FatBoy Capital LP
持有股份:3.73K
佔總股份比例:0.25%。
Caruso (James Joseph)
持有股份:1.84K
佔總股份比例:0.12%。
Jenkins (Casey A)
持有股份:310.00
佔總股份比例:0.02%。

Catheter Precision Inc的前三大股東類型是什麼?

Catheter Precision Inc 的前三大股東類型分別是:
Jenkins Family Charitable Institute
Jenkins (David A)
FatBoy Capital LP

有多少機構持有Catheter Precision Inc(VTAK)的股份?

截至2025Q3,共有23家機構持有Catheter Precision Inc的股份,合計持有的股份價值約為24.65K,占公司總股份的1.66% 。與2025Q2相比,機構持股有所增加,增幅為-11.22%。

哪個業務部門對Catheter Precision Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Catheter Precision Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI